Table 1.
Antimicrobial susceptibility of Vibrio spp. isolated over a one-year period.
| Antimicrobial | Number of Isolates | ||
|---|---|---|---|
| S 1 | I 2 | R 3 | |
| Amikacin | 116 (78.0%) | 12 (8.0%) | 21 (14.0%) |
| Cefotaxime | 111 (74.5%) | 11 (7.4%) | 27 (18.1%) |
| Imipenem | 147 (98.6%) | 0 | 2 (1.4%) |
| Amoxicillin-clavulanic acid | 133 (89.3%) | 7 (4.7%) | 9 (6.0%) |
| Ciprofloxacin | 135 (90.6%) | 11 (7.4%) | 3 (2.0%) |
| Ceftazidime | 134 (89.9%) | 4 (2.7%) | 11 (7.4%) |
| Tetracycline | 147 (98.6%) | 1 (0.7%) | 1 (0.7%) |
| Trimethoprim-sulfamethoxazole | 146 (98.0%) | 0 | 3 (2.0%) |
1 S–susceptible; 2 I–intermediate; 3 R–resistant.